CARIS DISCOVERY Trademark

Trademark Overview


On Wednesday, November 9, 2022, a trademark application was filed for CARIS DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the CARIS DISCOVERY trademark a serial number of 97670210. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 14, 2024. This trademark is owned by Caris Therapeutics, Inc.. The CARIS DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research and analysis services in the field of molecular biology, namely, identification of molecular targets for diagnosis, prognosis, and therapeutics in the field of healthcare; drug discovery services; pharmaceutical drug development services; Application service provider (ASP) featuring software using artificial intelligence for identifying novel targets across exome, transcriptome and cancer proteome to develop precision medicine-based medicines; Providing temporary use of on-line non-downloadable software using artificial intelligence for identifying novel targets across exome, transcriptome and cancer proteome to develop precision medicine-based medicines
caris discovery

General Information


Serial Number97670210
Word MarkCARIS DISCOVERY
Filing DateWednesday, November 9, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


NOT AVAILABLE"DISCOVERY"
Goods and ServicesMedical and scientific research and analysis services in the field of molecular biology, namely, identification of molecular targets for diagnosis, prognosis, and therapeutics in the field of healthcare; drug discovery services; pharmaceutical drug development services; Application service provider (ASP) featuring software using artificial intelligence for identifying novel targets across exome, transcriptome and cancer proteome to develop precision medicine-based medicines; Providing temporary use of on-line non-downloadable software using artificial intelligence for identifying novel targets across exome, transcriptome and cancer proteome to develop precision medicine-based medicines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 30, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCaris Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Party NameCaris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Trademark Events


Event DateEvent Description
Saturday, November 12, 2022NEW APPLICATION ENTERED
Wednesday, November 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 23, 2023ASSIGNED TO EXAMINER
Wednesday, August 30, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 30, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 1, 2024NON-FINAL ACTION WRITTEN
Monday, January 1, 2024NON-FINAL ACTION E-MAILED
Monday, February 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 17, 2024TEAS STATEMENT OF USE RECEIVED